2413 N Stock Overview
Provides medical-related services primarily to physicians and other healthcare professionals through Internet. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
My Notes
Capture your thoughts, links and company narrative
M3, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥183.50 |
| 52 Week High | JP¥331.83 |
| 52 Week Low | JP¥183.50 |
| Beta | 0.81 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -59.87% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2413 N | MX Healthcare Services | MX Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | n/a | 0% | 0% |
Return vs Industry: Insufficient data to determine how 2413 N performed against the MX Healthcare Services industry.
Return vs Market: Insufficient data to determine how 2413 N performed against the MX Market.
Price Volatility
| 2413 N volatility | |
|---|---|
| 2413 N Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in MX Market | 0% |
| 10% least volatile stocks in MX Market | 0% |
Stable Share Price: 2413 N has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 2413 N's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 12,100 | Itaru Tanimura | corporate.m3.com |
M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. The company operates through five reporting segments: Medical Platform, Evidence Solutions, Career Solutions, Site Solutions, and Overseas. It operates m3.com, a members-only web site for providing information to the healthcare professionals; MR-kun, where member doctors can independently and continuously receive information on the m3com platform; QOL-kun that provides life support information other than medical information to members; AskDoctors, where registered doctors answer questions about health and illness from the general public; MDLinx for medical professionals in the United States; and Doctors.net.uk, a website that provides developing services for pharmaceutical companies, as well as provides drug information database in France, Germany, and Spain.
M3, Inc. Fundamentals Summary
| 2413 N fundamental statistics | |
|---|---|
| Market cap | Mex$115.00b |
| Earnings (TTM) | Mex$5.76b |
| Revenue (TTM) | Mex$32.11b |
20.0x
P/E Ratio3.6x
P/S RatioIs 2413 N overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2413 N income statement (TTM) | |
|---|---|
| Revenue | JP¥245.70b |
| Cost of Revenue | JP¥102.56b |
| Gross Profit | JP¥143.13b |
| Other Expenses | JP¥99.03b |
| Earnings | JP¥44.11b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 64.95 |
| Gross Margin | 58.26% |
| Net Profit Margin | 17.95% |
| Debt/Equity Ratio | 6.8% |
How did 2413 N perform over the long term?
See historical performance and comparisonDividends
1.6%
Current Dividend Yield32%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/08/04 09:42 |
| End of Day Share Price | 2024/05/07 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
M3, Inc. is covered by 24 analysts. 13 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ritsuo Watanabe | BofA Global Research |
| Aaron Ho | CFRA Equity Research |
| Shuo Song | Citic Securities Co., Ltd. |